I'm happy to share that our article on #proton dosimetry for brain tumours in IJPT has been featured in a special article collection for Brain Cancer Awareness Month! #btsm Oncology Advance PTCOG-NA elsevier.com/subject/medici…

I'm happy to share that our work on slow-cycling melanoma cells has been featured in a special article collection for Melanoma and Skin Cancer Awareness Month! #melsm  Oncology Advance elsevier.com/subject/medici…

Antibody–drug conjugates are active in patients with HER2+ breast cancer brain metastases: where do we go from here? Read the editorial on the brain mets analysis from DB03 by Sarah Sammons (Dr Sarah Sammons) and Nancy Lin (@nlinmd) from Dana-Farber’s Breast Oncology Center. esmoopen.com/article/S2059-…

New 📢 #MerkelCellCarcinoma : ESMO–EURACAN Clinical Practice Guideline for diagnosis, treatment & follow-up. Algorithms also provided. MDT w/ high level of expertise should diagnose & make tx decisions. ow.ly/jTEk50RqzEw Iwona Lugowska Paolo A. Ascierto Piotr Rutkowski…

Unmissable editorial on the current status and next steps for studying and treating brain metastases in breast oncology: esmoopen.com/article/S2059-…

Young french oncologists from AERIO 😷💉💉💉 have been asked about their motivation for scientific carreers, here's what they said in ESMO Open
sciencedirect.com/science/articl…

Baudouin Courtier Matte Paul oui Laune Quentin Matthieu Delaye Maria Kfoury

📢📗
Merkel-cell carcinoma guideline of ESMO - Eur. Oncology and EURACAN

✅Management of locaregional and advanced/metastatic disease

👉doi.org/10.1016/j.esmo…

ESMO Open EADV Türk Dermatoloji Derneği The Skin Cancer Foundation 👒 Enes Erul MD Beliz Bahar Karaoğlan
OncoAlert OncoDaily
#cancer #oncology #skin #MedX

Out in ESMO Open the intracranial activity of T-DXd vs T-DM1 in the DESTINY-Breast03 phase 3 trial. Among patients with active brain mets, IC-ORR was 65.7% with T-DXd vs 34.3% with T-DM1. Accompanied by a podcast 🎙️ & an editorial by Dr Sarah Sammons Nancy Lin, MD. esmoopen.com/article/S2059-…

Impressive intracranial activity of both T-DXd (65%) and T-DM1 (34%) for HER2+ brain metastases.

🎙️ Don’t miss the accompanying podcast, where G Curigliano MD PhD and I had the opportunity to interview Sara Hurvitz and Nancy Lin, MD to discuss the results.

Spotify Link: open.spotify.com/episode/2JO8wQ…

Check out the Zebra of the Month video on neuroblastoma by Osmosis from Elsevier to learn about the causes, symptoms, and treatment options for this pediatric cancer. spkl.io/60174N8gc

In honour of Melanoma and Skin Cancer Awareness Month, dive into our curated collection of high-impact articles from Elsevier's Oncology Journal Network ➡️ spkl.io/601642cQ0 #melsm